RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Weifan Zheng to Drug Discovery

This is a "connection" page, showing publications Weifan Zheng has written about Drug Discovery.
Connection Strength

1.062
  1. Dong X, Ebalunode JO, Yang SY, Zheng W. Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling. Curr Comput Aided Drug Des. 2011 Sep 01; 7(3):181-9.
    View in: PubMed
    Score: 0.370
  2. Dong X, Ebalunode JO, Cho SJ, Zheng W. A novel structure-based multimode QSAR method affords predictive models for phosphodiesterase inhibitors. J Chem Inf Model. 2010 Feb 22; 50(2):240-50.
    View in: PubMed
    Score: 0.333
  3. Ebalunode JO, Zheng W. Molecular shape technologies in drug discovery: methods and applications. Curr Top Med Chem. 2010; 10(6):669-79.
    View in: PubMed
    Score: 0.330
  4. Law CJ, Ashcroft HA, Zheng W, Sexton JZ. Assay development and multivariate scoring for high-content discovery of chemoprotectants of endoplasmic-reticulum-stress-mediated amylin-induced cytotoxicity in pancreatic beta cells. Assay Drug Dev Technol. 2014 Sep; 12(7):375-84.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support